Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Xenodiagnosis After Antibiotic Treatment for Lyme Disease

ClinicalTrials.gov ID: NCT02446626

Public ClinicalTrials.gov record NCT02446626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Xenodiagnosis After Antibiotic Treatment for Lyme Disease - Phase II Study

Study identification

NCT ID
NCT02446626
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
72 participants

Conditions and interventions

Conditions

Interventions

  • Skin biopsy Procedure
  • Blood draw Procedure
  • Xenodiagnosis Device

Procedure · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 23, 2015
Primary completion
May 3, 2022
Completion
May 3, 2022
Last update posted
Jun 2, 2024

2015 – 2022

United States locations

U.S. sites
5
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
Mansfield Family Practice Storrs Connecticut 06268
National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland 20892
Tufts Medical Center Boston Massachusetts 02111
Stony Brook University (State University of New York) Stony Brook New York 11794-8153
New York Medical College Valhalla New York 10595

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02446626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02446626 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →